These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9833940)
41. Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat. Kappelle AC; Bravenboer B; van Buren T; Traber J; Erkelens DW; Gispen WH Br J Pharmacol; 1993 Mar; 108(3):780-5. PubMed ID: 8467365 [TBL] [Abstract][Full Text] [Related]
42. Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine. Saini AK; Arun KH; Kaul CL; Sharma SS Pharmacol Res; 2004 Dec; 50(6):593-9. PubMed ID: 15501697 [TBL] [Abstract][Full Text] [Related]
43. Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats. Tominaga M; Igarashi M; Daimon M; Eguchi H; Matsumoto M; Sekikawa A; Yamatani K; Sasaki H Endocr J; 1993 Jun; 40(3):343-9. PubMed ID: 7920888 [TBL] [Abstract][Full Text] [Related]
44. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats. Moore SA; Peterson RG; Felten DL; O'Connor BL J Neurol Sci; 1980 Oct; 48(1):133-52. PubMed ID: 6448276 [TBL] [Abstract][Full Text] [Related]
45. Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats. Suh KS; Oh SJ; Woo JT; Kim SW; Yang IM; Kim JW; Kim YS; Choi YK; Park IK Korean J Intern Med; 1999 Jul; 14(2):34-40. PubMed ID: 10461423 [TBL] [Abstract][Full Text] [Related]
46. Effect of honey and insulin treatment on oxidative stress and nerve conduction in an experimental model of diabetic neuropathy Wistar rats. Sirisha A; Gaur GS; Pal P; Bobby Z; Balakumar B; Pal GK PLoS One; 2021; 16(1):e0245395. PubMed ID: 33449943 [TBL] [Abstract][Full Text] [Related]
47. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy. Bachewal P; Gundu C; Yerra VG; Kalvala AK; Areti A; Kumar A Biofactors; 2018 Mar; 44(2):109-122. PubMed ID: 29193444 [TBL] [Abstract][Full Text] [Related]
48. Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats. Van der Zee CE; Van der Hoop RG; Gispen WH Diabetes; 1989 Feb; 38(2):225-30. PubMed ID: 2536628 [TBL] [Abstract][Full Text] [Related]
49. Date fruit extract is a neuroprotective agent in diabetic peripheral neuropathy in streptozotocin-induced diabetic rats: a multimodal analysis. Zangiabadi N; Asadi-Shekaari M; Sheibani V; Jafari M; Shabani M; Asadi AR; Tajadini H; Jarahi M Oxid Med Cell Longev; 2011; 2011():976948. PubMed ID: 22191015 [TBL] [Abstract][Full Text] [Related]
50. Effects of cilostazol on the peripheral nerve function and structure in STZ-induced diabetic rats. Uehara K; Sugimoto K; Wada R; Yoshikawa T; Marukawa K; Yasuda Y; Kimura Y; Yagihashi S J Diabetes Complications; 1997; 11(3):194-202. PubMed ID: 9174902 [TBL] [Abstract][Full Text] [Related]
51. Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats. Miyauchi Y; Shikama H; Takasu T; Okamiya H; Umeda M; Hirasaki E; Ohhata I; Nakayama H; Nakagawa S Eur J Endocrinol; 1996 Apr; 134(4):467-73. PubMed ID: 8640299 [TBL] [Abstract][Full Text] [Related]
52. Acetyl-L-carnitine effects on nerve conduction and glycemic regulation in experimental diabetes. Soneru IL; Khan T; Orfalian Z; Abraira C Endocr Res; 1997; 23(1-2):27-36. PubMed ID: 9187536 [TBL] [Abstract][Full Text] [Related]
53. [Experimental diabetic neuropathy. Morphometric studies on the rat N. suralis in short-term streptozotocin-induced diabetes]. Wattig B; Warzok R; Thomas PK Zentralbl Allg Pathol; 1986; 131(5):451-8. PubMed ID: 3526747 [TBL] [Abstract][Full Text] [Related]
54. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Isshiki K; Haneda M; Koya D; Maeda S; Sugimoto T; Kikkawa R Diabetes; 2000 Jun; 49(6):1022-32. PubMed ID: 10866056 [TBL] [Abstract][Full Text] [Related]
55. Effects of long-term treatment with alpha-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: a genetic model for type 2 diabetes. Wada R; Koyama M; Mizukami H; Odaka H; Ikeda H; Yagihashi S Diabetes Metab Res Rev; 1999; 15(5):332-7. PubMed ID: 10585619 [TBL] [Abstract][Full Text] [Related]
56. High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats. van Dam PS; Bravenboer B; van Asbeck BS; Marx JJ; Gispen WH Eur J Pharmacol; 1999 Jul; 376(3):217-22. PubMed ID: 10448879 [TBL] [Abstract][Full Text] [Related]
57. Neuroprotective effect of cerium oxide nanoparticles in a rat model of experimental diabetic neuropathy. Najafi R; Hosseini A; Ghaznavi H; Mehrzadi S; Sharifi AM Brain Res Bull; 2017 May; 131():117-122. PubMed ID: 28373151 [TBL] [Abstract][Full Text] [Related]
58. Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats. Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Komori H; Sakamoto N Diabetes; 1992 May; 41(5):587-91. PubMed ID: 1533192 [TBL] [Abstract][Full Text] [Related]
59. Troglitazone protects human erythrocytes from oxidant damage. May JM; Qu ZC Antioxid Redox Signal; 2000; 2(2):243-50. PubMed ID: 11229529 [TBL] [Abstract][Full Text] [Related]
60. The neuroprotective effects of progesterone on experimental diabetic neuropathy in rats. Sameni HR; Panahi M; Sarkaki A; Saki GH; Makvandi M Pak J Biol Sci; 2008 Aug; 11(16):1994-2000. PubMed ID: 19266905 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]